Eventide Asset Management, LLC 13D/13G Filings for Freeline Therapeutics Holdings plc (FRLN)

Eventide Asset Management, LLC 13D and 13G filings for Freeline Therapeutics Holdings plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-14
1:54 pm
Purchase
2022-12-3113GFreeline Therapeutics Holdings plc
FRLN
Eventide Asset Management, LLC394,718
9.100%
162,341increase
(+69.86%)
Filing
2022-02-14
11:47 am
Purchase
2021-12-3113GFreeline Therapeutics Holdings plc
FRLN
Eventide Asset Management, LLC232,377
9.700%
66,667increase
(+40.23%)
Filing
2021-02-12
4:07 pm
Purchase
2020-12-3113GFreeline Therapeutics Holdings plc
FRLN
Eventide Asset Management, LLC165,710
7.500%
165,710increase
(New Position)
Filing